May 23, 20221 min readTABALISSE First and Only SYK Inhibitor for Immune Thrombocytopenia ~ 6/9/22 @ 6:30pmClick here to register today!
The First and Only Novel Targeted Therapy Approved for mCRC, Regardless of Mutation Status, in More Than a Decade1-3
Comments